These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32445870)

  • 1. Venom-derived modulators of epilepsy-related ion channels.
    Chow CY; Absalom N; Biggs K; King GF; Ma L
    Biochem Pharmacol; 2020 Nov; 181():114043. PubMed ID: 32445870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion channels and epilepsy.
    Armijo JA; Shushtarian M; Valdizan EM; Cuadrado A; de las Cuevas I; Adín J
    Curr Pharm Des; 2005; 11(15):1975-2003. PubMed ID: 15974971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
    Klint JK; Senff S; Rupasinghe DB; Er SY; Herzig V; Nicholson GM; King GF
    Toxicon; 2012 Sep; 60(4):478-91. PubMed ID: 22543187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
    Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
    Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion Channels-related Neuroprotection and Analgesia Mediated by Spider Venom Peptides.
    Nogueira Souza AC; Binda NS; Almeida HY; de Castro Júnior CJ; Gomez MV; Ribeiro FM; Da Silva JF
    Curr Protein Pept Sci; 2023; 24(5):365-379. PubMed ID: 37018532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
    Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
    Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets for antiepileptic drug development.
    Meldrum BS; Rogawski MA
    Neurotherapeutics; 2007 Jan; 4(1):18-61. PubMed ID: 17199015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The h-channel: a potential channelopathy in epilepsy?
    Poolos NP
    Epilepsy Behav; 2005 Aug; 7(1):51-6. PubMed ID: 15961349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BmK AEP, an Anti-Epileptic Peptide Distinctly Affects the Gating of Brain Subtypes of Voltage-Gated Sodium Channels.
    Zhang F; Wu Y; Zou X; Tang Q; Zhao F; Cao Z
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion channels: gate expectations.
    Garcia ML
    Nature; 2004 Jul; 430(6996):153-5. PubMed ID: 15241399
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on peptide drugs for voltage-gated calcium channels.
    Gao L
    Recent Pat CNS Drug Discov; 2010 Jan; 5(1):14-22. PubMed ID: 19751208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Ion Channels by Cysteine-Rich Peptides: From Sequence to Structure.
    Mobli M; Undheim EAB; Rash LD
    Adv Pharmacol; 2017; 79():199-223. PubMed ID: 28528669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modeling of peptide toxin-ion channel interactions using RosettaDock.
    Mateos DL; Yarov-Yarovoy V
    Proteins; 2023 Jul; 91(7):872-889. PubMed ID: 36729043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two tarantula peptides inhibit activation of multiple sodium channels.
    Middleton RE; Warren VA; Kraus RL; Hwang JC; Liu CJ; Dai G; Brochu RM; Kohler MG; Gao YD; Garsky VM; Bogusky MJ; Mehl JT; Cohen CJ; Smith MM
    Biochemistry; 2002 Dec; 41(50):14734-47. PubMed ID: 12475222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin. Antiepileptic mechanism of action.
    Kelly KM
    Neuropsychobiology; 1998 Oct; 38(3):139-44. PubMed ID: 9778601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of currently used antiseizure drugs.
    Sills GJ; Rogawski MA
    Neuropharmacology; 2020 May; 168():107966. PubMed ID: 32120063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ion channels and epilepsy].
    Armijo JA; de las Cuevas I; Adín J
    Rev Neurol; 2000 Jun; 30 Suppl 1():S25-41. PubMed ID: 10904966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and venom peptides: new modalities for ion channels.
    Wulff H; Christophersen P; Colussi P; Chandy KG; Yarov-Yarovoy V
    Nat Rev Drug Discov; 2019 May; 18(5):339-357. PubMed ID: 30728472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cone venom--from accidental stings to deliberate injection.
    McIntosh JM; Jones RM
    Toxicon; 2001 Oct; 39(10):1447-51. PubMed ID: 11478951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion channels as important targets for antiepileptic drug design.
    Yogeeswari P; Ragavendran JV; Thirumurugan R; Saxena A; Sriram D
    Curr Drug Targets; 2004 Oct; 5(7):589-602. PubMed ID: 15473249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.